AmerisourceBergen Corp. matched consensus estimates for profit and revenue for its fiscal first quarter on Wednesday, and raised its full-year guidance. The Conshocken, Pa.-based drug distribution company posted net income of $449 million, or $2.13 a share, for the quarter to Dec, 31, up from $374.8 million, or $1.81 a share, in the year-earlier period. Adjusted per-share earnings came to $2.58, matching the FactSet consensus. Revenue rose 13.5% to $59.6 billion from $52.5 billion, also matching the FactSet consensus. The company is now expecting fiscal 2022 adjusted EPS of $10.60 to $10.90, up from prior guidance of $10.50 to $10.80. The FactSet consensus is for EPS of $10.69.Shares were not yet active premarket, but have gained 30% in the last 12 months, while the S&P 500 has gained 20%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.